Am­gen’s Brad­way elect­ed PhRMA chair; Abing­worth pro­vides £13M A round to an­tivi­ral start­up Viri­on­Health

→ Am­gen CEO Robert Brad­way was named chair­man-elect of PhRMA ef­fec­tive im­me­di­ate­ly. Sanofi CEO Olivi­er Brandi­court will be­come chair­man-elect and James Robin­son, pres­i­dent, Astel­las Amer­i­c­as, will as­sume the role of board trea­sur­er ef­fec­tive Feb­ru­ary 7, 2018.

→ Abing­worth has hand­ed over a £13 mil­lion Se­ries A to Viri­on­Health for its work on new drugs for res­pi­ra­to­ry vi­ral in­fec­tions. The biotech is based on the lab work of Nigel Dim­mock and An­drew Eas­t­on at the Uni­ver­si­ty of War­wick’s School of Life Sci­ences. Roche vet Nico­la Thomp­son is tak­ing the CEO post at the com­pa­ny. “We are de­light­ed to re­ceive this sup­port and will use the funds to ad­vance our nov­el pro­grammes in­to the clin­ic,” said Jef­frey Al­mond, chair­man of Viri­on­Health. “Up­per res­pi­ra­to­ry tract in­fec­tions re­main an im­por­tant un­met need which in­cludes an es­ti­mat­ed 1 bil­lion cas­es of in­fluen­za across the globe each year.”

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN